Communications
DOI: 10.1002/anie.201006204
Domino Reactions
One-Pot High-Yielding Synthesis of the DPP4-Selective Inhibitor
ABT-341 by a Four-Component Coupling Mediated by a
Diphenylprolinol Silyl Ether**
Hayato Ishikawa, Masakazu Honma, and Yujiro Hayashi*
In a “one-pot” reaction, several transformations are carried
out to form several bonds in a single flask.[1] Such reactions
remove the need for several purification steps, minimize the
generation of chemical waste, and save time; thus, they can be
viewed as “green” processes. However, there are several
challenges to be overcome in a one-pot reaction: 1) There are
reactions that are not suitable for a one-pot reaction. The
reaction has to be performed in the presence of the products
generated in the previous reactions. When A reacts with B to
generate C, along with D, the next reaction has to be carried
out in the presence of D, which might cause a problem. In the
Horner–Wadsworth–Emmons reaction, for example, a phos-
phoric acid derivative would be generated in an equimolar
amount as a side product. 2) As the number of transforma-
tions increases, the amount of other compounds present
increases. Furthermore, each transformation has to proceed in
high yield. 3) There is a limitation in terms of solvent usage.
When the best solvents for successive reactions are different,
a solvent with a high boiling point cannot be used for the
earlier reaction because of the difficulty of its removal under
reduced pressure. 4) The reagents that can be employed are
limited. If a reactive reagent remains, it might influence the
subsequent reaction. The exact stoichiometric amount of the
reagent has to be used, or a low-boiling reagent has to be
employed, in which case the excess reagent can be removed
under reduced pressure. Thus, there are several limitations in
a one-pot reaction, and a one-pot reaction is not a simple
connection of each optimized reaction.
turally, it possesses an amide part and, on the other side of the
carbonyl group, a cyclohexene moiety with a trifluorophenyl
and an amino forming two contiguous stereogenic centers.
Chiral ABT-341 (1) has been synthesized in 11 steps;[3] the
key chiral disubstituted methyl cyclohexenecarboxylate was
prepared by separation of the enantiomers by preparative
HPLC on a chiral phase. Thus, an efficient enantioselective
synthesis of ABT-341 (1) would be highly desirable.
Our strategy for the synthesis of ABT-341 (1) began with
the construction of a disubstituted cyclohexenecarboxylate
with the correct absolute and relative configurations. The rest
of the reactions were transformations of the functional groups
and amide-bond formation. Recently, we completed the
synthesis of (À)-oseltamivir through two one-pot reactions,[4]
which also involved a cyclohexenecarboxylate as a key
structure (Scheme 1). Although the synthetic approach to
ABT-341 (1) was similar to that used for our synthesis of (À)-
Scheme 1. Structures of ABT-341 (1) and oseltamivir.
Dipeptidyl peptidase IV (DPP4, also known as CD26), a
110 kDa serine protease that is ubiquitously distributed in the
body, deactivates glucose-regulating hormones, such as GLP-
1 and GIP. Thus, DPP4 inhibition has become a useful therapy
for type 2 diabetes.[2] ((4R,5S)-5-Amino-4-(2,4,5-trifluorophe-
nyl)cyclohex-1-enyl)-(3-(trifluoromethyl)-5,6-dihydro-
[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341
(1)) is a highly potent, selective, and orally bioavailable
DPP4 inhibitor developed by Abbott Laboratories.[3] Struc-
oseltamivir, the synthesis of ABT-341 (1) through a one-pot
reaction is more challenging for several reasons. Although a
chiral trisubstituted cyclohexene was prepared in the first
one-pot reaction in the synthesis of (À)-oseltamivir, not only
the preparation of the chiral cyclohexene but also further
transformations, such as the formation of the amide bond and
functional-group manipulations, have to be performed in one
flask in the case of ABT-341 (1). That is, after the construction
of the chiral cyclohexene framework, several transformations
have to be carried out in the same flask in the presence of
several products, such as (EtO)2P(O)OH. Control of the
relative and absolute configurations at C4 and C5 of the
cyclohexene ring is another key issue.
The one-pot reaction to form ABT-341 (1) from four
components is summarized in Scheme 2. Thus, an initial
enantioselective Michael reaction of acetaldehyde (3) and
nitroalkene 2 in the presence of the diphenylprolinol silyl
ether organocatalyst 4,[5,6] followed by the successive addition
of vinyl phosphonate 5, trifluoroacetic acid (TFA), amine 6
[*] Dr. H. Ishikawa, M. Honma, Prof. Dr. Y. Hayashi
Department of Industrial Chemistry, Faculty of Engineering
Tokyo University of Science
Kagurazaka, Shinjuku-ku, Tokyo 162-8601 (Japan)
Fax: (+81)3-5261-4631
E-mail: hayashi@ci.kagu.tus.ac.jp
[**] DPPA=dipeptidyl peptidase IV.
Supporting information for this article is available on the WWW
2824
ꢀ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2011, 50, 2824 –2827